Thursday 30 June 2016

Prefilled Syringes Market - An Early Market Opportunity for Healthcare Industry

In the injectable drug delivery devices market, the prefilled syringes segment is one of the fastest growing segments. Various benefits of prefilled syringes including reduced risk of cross contamination, and ease of handling and administration have led to their increased demand in the market. 


The report states that the continuous growth in the injectable drugs market worldwide has boosted the growth of the global prefilled syringes market. The advantages of prefilled syringes over conventional vials and syringe packing systems have supported the market’s growth. Increase in the demand for point-of-care administration and technological advancements in the manufacturing of prefilled syringes are expected to augment the growth of the market during the forecast horizon. However, the introduction of alternative drug delivery methods might hamper the growth of the market.

Transparency Market Research has recently published a report on the global prefilled syringes market. The report, titled “Prefilled Syringes Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019,” offers an insightful study on the global prefilled syringes market and projects the expansion of the market at a CAGR of 13.3% during the period from 2013 to 2019. The global prefilled syringes market stood at a valuation of US$2.09 bn in 2012 and is anticipated to be worth US$4.98 bn by 2019. The report identifies the key factors impacting the growth of the market and profiles some of the prominent players in the market. 

Some of the key players in the global prefilled syringes market are Schott AG, Gerresheimer AG, Becton, Dickinson and Company, Nipro Corporation, Baxter International Inc., Ypsomed Holding AG, Stevanato Group, Unilife Corporation, Bespak, West Pharmaceutical Services, Inc., and Vetter Pharma International GmbH. These players have been profiled on the basis of company overview, product portfolio, and financial overview. For the new and existing players in the market, the report offers strategic recommendations such as the adoption of polymer technology for the manufacturing of prefilled syringes and investments in the emerging markets in North America.

Tuesday 28 June 2016

Viscosupplementation Market: Process Development and New Drugs Reveal Mammoth Opportunities for Growth

A new market research study by Transparency Market Research presents an in-depth analysis of the global viscosupplementation market, emphasizing on the current trends and major growth prospects. The research study, titled “Viscosupplementation Market - Global Industry Analysis, Size, Share, Trends and Forecast 2016 – 2023,” covers the key drivers, restraints, product segmentation, geographical segmentation, and competitive scenario. The research report draws from analytical tools to determine the opportunities and challenges in the global viscosupplementation market.


Osteoarthritis is considered as one of the most common forms of arthritis, affecting millions of people across the globe. As of now, there is no complete cure available for osteoarthritis of the knee; however, numerous treatment options help in slowing down the condition’s progression. In the initial stage, osteoarthritis is treated by non-surgical methods, however if the patient still observes pain then doctors consider the option of viscosupplementation. In this process, a gel-like fluid, known as hyaluronic acid, is injected into the knee joint of the patient. This fluid acts as a lubricant allowing the bones to move easily over each other.

The growing awareness regarding the new drugs and innovative devices available for treating osteoarthritis are the key factors projected to drive the global viscosupplementation market throughout the forecast period. In addition, the growing geriatric population, increasing obese population, and rising demand for minimally invasive surgical processes are some of the other factors estimated to fuel the growth of the market in the next few years. Process development and product innovation are further contributing substantially towards the growth of the global viscosupplementation market.


At present, North America accounts for the largest share in the global viscosupplementation market owing to the growing awareness regarding the treatments available and rising product demand. On the other hand, the Europe viscosupplementation market is witnessing a significant fall in the market share due to the rising difficulties in reimbursement policies. However, this region is projected to witness a revival and create potential opportunities for viscosupplementation products in the forecast period. Furthermore, the Asia Pacific and Rest of the World viscosupplementation markets are anticipated to witness significant growth in the near future, thanks to the improving healthcare facilities and economic development here.

The prominent players operating in the global viscosupplementation market include Fidia Farmaceutici SpA, GALDERMA S.A., Ferring Pharmaceuticals, Inc., Hyaltech Ltd., LifeCore Biomedical LLC, F. Hoffmann-La Roche Ltd., Alcon, Inc., Anika Therapeutics, Inc., and Allergan, Inc. The report has provided detailed vendor analysis and profiles of the leading players in order to present a clear understanding of the global viscosupplementation market. The growing demand for viscosupplementation procedures is expected to encourage the entry of new market players in the coming years.

Monday 27 June 2016

Rapid Rise In 3G/4G Reaching More Consumers Dictate Video Telemedicine Market's Growth

The rapid penetration of broadband internet will impel the growth of the video telemedicine market, finds a latest report by Transparency Market Research. The report titled "Video Telemedicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020", says that by 2020, the market valuation will touch US$1,624.4 mn, up from US$559.0 million as of 2013. The global video telemedicine market is expected to register a CAGR of 16.5% between 2014 and 2020, the report further states. 


With age come a variety of mobility issues. As the world's graying population base expands dramatically, there is a pressing need for healthcare services and specialists to reach out to these aged individuals rather than the other way round. This factor will lead to an unprecedented interest in the deployment of video telemedicine solutions, especially in countries where the majority of the population is already connected to the internet. In both developed and underserved regions of the world, governments have realized the many benefits of video telemedicine consultations, creating a smoother path for the growth for the global video telemedicine market.

The key restraints that will stand in the way of the market's growth, however, are: Reluctance to adopt new technologies, a dearth of skilled staff to enable the seamless deployment of video telemedicine, and the underdeveloped network infrastructure in many regions of the world. Companies in the telemedicine market can find a way around these problems by introducing integrated telemedicine solutions that are easy to use and cost less than the existing options. With the aim to drill down to the second and third level of the global video telemedicine market, the report segments the market by communication technology into: 3G (GSM, CDMA, Others), Satellite Communications, 4G (LTE, WiMax & Others), Broadband Integrated Services Digital Network (B-ISDN), and Asymmetric Digital Subscriber Line (ADSL).

Furthermore, the report provides extensive qualitative information about the following communication technologies in the context of the video telemedicine market: Asynchronous Transfer Mode (ATM) and IP Multimedia Systems (NYSE:IMS). The highest revenue generating segment in 2013 in the global video telemedicine market, according to the report, was that of ADSL-based video telemedicine segment. However, as the adoption of 4G spreads across the world, the 4G-based video telemedicine segment is poised on the brink of seeing impressive growth. By application, the global video telemedicine market is segmented into dermatology, cardiology, gynecology, psychiatry and neurology, oncology, orthopedics, dentistry, radiology, and orthopedics. While video telemedicine was most widely used for gynecology-related consultation in 2013, the use of neurology and psychiatry segment will see patients and doctors heavily relying on video telemedicine in the coming years. As a result, the neurology and psychiatry segment will exhibit a remarkable 17.0% CAGR from 2014 to 2020. 


North America saw the highest use of video telemedicine and will continue to remain the key market over the near future. Projected to expand at a CAGR of 15% through the report's forecast period, companies will continue to invest considerably in the North America video telemedicine market. Companies profiled in the report include: ZTE Corporation, Siemens Healthcare, Global Media Group, LLC., LifeSize Communications, Inc., AMD Global Telemedicine, Inc., Sony Corporation, Logitech International S.A., Vidyo, Inc., Premiere Global Services, Inc., and Huawei Technologies Co. Ltd.

Wednesday 22 June 2016

TMR Releases Research Paper, “Scar Treatment Market” – Evolving Trends 2024

Often considered a concept that draws from wound care and first aid, scar treatment has emerged as a niche market promising high growth to medical device manufacturers. However, products used in scar therapy are far more advanced than conventional first-aid adhesives. Driven by innovations, demand in the U.S. scar treatment market is poised to surge exponentially between 2016 and 2024.

A scar is any mark on the skin caused by injury, burns, surgery, acne, or inflammation of tissue. Scars
can impact the mental and physical well-being of an individual, resulting in poor self-esteem, depression, embarrassment, and altered social interactions. Scars can be of various types depending on their age, color, shape, and sizes. The incidence of skin problems leading to scar formation is significantly high in the U.S., which is driving the scar treatment market in the country.

Additionally, the U.S. scar treatment market is significantly gaining from the easy availability of technologically advanced products with the capability of fading apparent scars. The growing geriatric population and rising consciousness about appearance among consumers are also aiding the expansion of the scar treatment market in the U.S. Increasing expenditure on personal grooming also has been boosting the U.S. scar treatment market.

A comprehensive overview of the U.S. scar treatment market has been provided in the report. The factors impacting the market’s growth are studied in detail. The report also presents insights into the growth drivers and restraints that are expected to influence the market’s trajectory during the forecast period. Some of the companies operating in the market are profiled in the report to examine the competition prevailing in the U.S. scar treatment market.

The increasing disposable income of consumers and rising economic growth are cited as reasons for the revenue generated from the increasing sale of scar treatment products. It is important to note that while the treatment of keloids and burn scars is considered medically important by regulatory bodies, the treatment of mild to medium acne and spot correction is not considered a medical necessity. However, a rise in the affluence of the population has been fuelling the demand for aesthetic corrective procedures such as dermal filling, wrinkle reduction, volume restoration, and laser treatment.

Botulinum type-A injections and hyaluronic acid based dermal fillers are primarily used for aesthetically improving a person’s appearance.


The U.S. scar treatment market is also significantly gaining from the increasing demand for combination therapeutics in scar treatment to enhance the effectiveness of procedures and shorten the time taken for treatment.

The various products available in the U.S. scar treatment market include ointments, creams, gels, oils, and sprays. These products have proven helpful in reducing redness, bumps, pain, and itching caused by scars. Since these products can mostly be applied onto scars without any medical supervision, demand for them is quite high in the U.S. Additionally, the demand for minimally invasive surgical treatments and laser treatments has also significantly increased for the treatment of more severe scars.  

On the flip side, some of restraints witnessed by the market include the increasing awareness about the side effects associated with the usage of scar treatment products. The high cost of scar treatment therapies also has an adverse impact on the scar treatment market in the U.S.

Wednesday 8 June 2016

Global Medical Tourism Market to Witness Increasing Influx of Medical Tourists in Asian Countries

The increasing number of people travelling abroad to seek medical treatment comprises a rising global trend. The exponentially rising healthcare cost in developed regions, coupled with the availability of advanced yet cost-effective medical services in developing countries, is encouraging people to travel abroad for treatment purposes that may also incorporate an extended holiday. This trend is called medical tourism and has been showcasing definitive growth around the world over the past few years. 

Brochure Download:


Demand for Advanced and Cost-effective Medical Services Boosts Global Medical Tourism Market

Medical tourism may include sophisticated treatments such as neurosurgery, cardiac surgery, orthopedics, elective treatments such as cosmetic surgeries and dental care, or routine health check-ups. The visibly rising cost of healthcare services in developed countries is the prime factor bolstering the market for medical tourism. According to a report published by Transparency Market Research, approximately 50 million people in the U.S. alone are uninsured, while 139 million Americans do not have dental insurance.

An estimated 1.6 million Americans opted for medical tourism in 2012, since the treatment for the same disease in developing nations costs 20% to 30% less than that in developed countries. This helps patients and their families save a substantial share of the cost even after accounting for the travel expenses. 

The global medical tourism market, therefore, sees lucrative opportunities in the forthcoming years with an increasing number of people making it their preferred choice. Transparency Market Research, in its latest report, pegs the overall value of the global medical tourism market at US$10.5 bn in 2012, and it is expected to reach US$32.5 bn by the end of 2019. If the figures hold true, the global medical tourism market will exhibit an impressive CAGR of 17.9% between 2013 and 2018.

Asian Countries Witness Highest Influx of Medical Tourists

With high-quality infrastructure and low costs, Asian countries have emerged as the most prominent players in the market for medical tourism over the past few years. Asia attracted over 5.6 million foreign patients in 2012, generating a revenue of a whopping US$6.4 bn from medical tourism. The presence of popular tourist destinations in this region has also contributed to attracting an increasing number of people from abroad. 

India, Thailand, Malaysia, Singapore, South Korea, and Taiwan are among the Asian countries that witness the highest number of people travelling from abroad to seek medical services. For instance, Thailand has emerged as the most popular destination for medical tourists from Western Europe for cosmetic surgeries.  In 2012, Thailand received over 2.5 million foreign patients that accounts for almost 45% of the total number of foreign arrivals in Asia. Likewise, India and Singapore specialize in complex procedures such as cardiac surgeries. In the meantime, Malaysia also has been attracting a large number of medical tourists due to the presence of a modern healthcare infrastructure. 

Favorable Government Policies May Boost Global Medical Tourism Market

The medical tourism market is still in a nascent stage and requires substantial coordination among healthcare providers, insurers, and governments to enjoy sustainable growth in the near future. With favorable government policies, the organizations operating in the market can enjoy a competitive advantage. Some of the most prominent names operating in this industry include Bumrungrad Hospital, Apollo Enterprise Ltd, Bangkok Medical Center, Prince Court Medical Center, Raffles Medical Group, and others.


The Evolving Veterinary Radiography Systems Market: Expert Insights

Animal radiography employs similar techniques used on humans as a tool to diagnose diseases and injuries. Veterinary radiography comprises of several imaging modalities such as CT, MRI, PET, X-rays and others similar and combinational form of devices. Images captured by these imaging modalities can either be stored on a film or can be directly send to a storage device in a digital format.

Veterinary radiography system is broadly classified into two prominent categories: computed radiography and direct digital radiography. Computed radiography requires cassettes having semiconductor plate that are exposed to radiation and seeks a specialized electronic reader. In direct digital radiography system a cesium iodide scintillator array absorbs the radiation wherein light pulse is detected by a large array of amorphous silicon photodiode elements.

Over the years computed radiography system is rapidly being phased out owing to advantages of using a digital radiography system. Benefits of using a digital radiography encompasses safety and high shelf life of the records, reduced image generation time and immediate interpretation. Moreover the ability to transfer images to a remote locations i.e. teleradiology has also increased the adoption rate of digital radiology devices. It is increasingly difficult to find film cassettes and screens for medical radiography sold by primary vendors. Despite this, digital radiography still cannot match the spatial resolution of computed radiography systems yet newer systems are narrowing the gap.


X-ray is perhaps one of the first tests a veterinarian will administer for a sick or injured animal in order to assess and diagnose its condition. For small animals X-ray devices can be mounted over a table whereas for larger animals such as cows and horses a free floating machine is usually employed. Computed tomography (CT) provides three dimensional hi-resolution cross section images of internal organs and bones.  

The shift toward digital imaging has eventually resulted in the development of new formats and systems for image storage. As images captured in the digital format can be easily altered or manipulated a specialized medical image format known as Digital Imaging and Communication in Medicine (DICOM) has been adopted in various countries. A salient feature of this format is a hidden header to record any manipulation made in the file. It also records every instance of the file being saved. The reader is saved within the image file. Thanks to this, any accidental or deliberate manipulation of the image can be spotted and tracked easily.

Despite of high resolution and clarity CT scans for larger animals still a challenging task for veterinary physician. MRIs are also used in animal radiography, but they can be very expensive and are consequently not used as often. Digital fluoroscopy procedure assists in conducting venography, vascular studies and contrast GI studies wherein a radio contrast agent is injected to map the digestive tract or blood vessels. The Food and Drug Administration (FDA) does not mandate 510(k) or formal pre-market approval for devices that are used in veterinary medicine. Companies manufacturing radiation-emitting devices, however, are needed to duly register their products according to the prevailing radiological health regulations. These are administered by the Center for Devices Radiological Health (CDRH).

Geographically the market is largely dominated by the developed regions such as the United States and Europe owing to the presence of the established market for radiography systems. Asia Pacific and Rest of the World market are among the fastest growing market due to growing animal health awareness and the ability of veterinarians to provide diagnostic services for animal health. Some of the prominent players in the market include Sedecal USA, Lake Superior X-Ray, Inc., Siemens AG, Toshiba Corporation, Universal Medical Systems, Inc. are a few of prominent players.

Tuesday 7 June 2016

Laboratory Plasticware Market Gains Impetus from Policies Mandating Enhanced Safety in Laboratories

The use of plasticware across laboratory applications has significantly risen thanks to its cost-effectiveness. A new report by Transparency Market Research (TMR), provides a comprehensive overview of the global laboratory plasticware market. It presents insights into the factors influencing the market’s trajectory between 2013 and 2019. The report is titled “Laboratory Plasticware Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

Laboratory plasticware is made from polymers and has diverse applications across laboratory and research centers. The market for laboratory plasticware has significantly evolved in the last few years in terms of design, material composition, and application. Laboratory equipment or apparatuses made from polymers is being preferred because of their unbreakable nature. This property also enhances their applicability in handling radioactive isotopes and hazardous and carcinogenic substances or chemicals. 


The demand for laboratory plasticware is thus increasing at a rapid pace due to its properties such as reusability, environment friendliness, and thermostability. Moreover using laboratory plasticware ensures better safety to laboratory personnel than glass apparatuses.  

Some of the most commonly used laboratory plasticware includes beaker, spirator bottles, Buchner funnel, centrifuges, micro centrifuge tubes, and carrier tray. Laboratory plasticware is also gaining considerable acceptance in cryopreservation and cell culture related experiments and studies. With advances in technology, various chemical compositions are used for manufacturing laboratory plasticware. Such developments are expected to reflect positively on the overall sales reported by the market. 

Despite witnessing growth at a steady rate, the market for laboratory plasticware in the U.S. and Europe is threatened by government cuts in funding for research and development. The reluctance of private companies for investing in R&Ds is also expected to have a negative impact on the market. Nevertheless, as per the report, the U.S. will continue to remain the largest market for plasticware laboratory equipment owing to the presence of a large number of research centers and universities in the nation. 

The global laboratory plasticware market also witnesses rising demand in the emerging economies of Asia Pacific such as India, Singapore, China, and Japan. The surging economies of these countries are providing lucrative opportunities for the market vendors to capitalize on. The prevalence of stringent regulations mandating enhanced safety across the laboratory also aids the expansion of the global laboratory plasticware market. 

The countries encompassed within the Rest of the World are yet to emerge as attractive markets for laboratory plasticware. However, favorable government policies are attracting top notch R&D companies in these countries, which is expected to positively impact the laboratory plasticware market. 

To present a holistic report on the prevailing competitive landscape, the report also profiles companies such as Eppendorf AG, Duran Group GmbH, Thermo Fisher Scientifi, Inc., Mettler-Toledo International Inc., Wheaton Science Products, and others.